How Can I Save My Sex Life After Breast Cancer?
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
In this episode of Gyno Info Frank Talk with Dr. Burki addresses concerns regarding vaginal estrogen use in breast cancer survivors, discussing a new study from the March 2025 issue of the American Journal of Obstetrics and Gynecology. She explains common symptoms of urogenital atrophy, which results from estrogen loss and can be exacerbated by cancer treatments. The study reveals that low-dose vaginal estrogen does not increase breast cancer recurrence or mortality, offering solace to patients and physicians. Dr. Burki emphasizes the importance of informed, open discussions between doctors and patients regarding off-label use.
00:00 Introduction to Gyno Info Frank Talk
00:53 Welcome and Overview of the Podcast
01:18 Personal Anecdote and Professional Commitment
02:48 Understanding Urogenital Atrophy
05:21 Causes and Symptoms of Estrogen Loss
07:21 Study on Vaginal Estrogen for Breast Cancer Survivors
10:23 Off-Label Use and FDA Guidelines
12:19 Conclusion and Listener Engagement
13:32 Final Thoughts and Contact Information
You can write to us at Questions@GynoInfo.net
And follow us on Instagram @gynoinfo